Just in:
Amid Mounting Global Health Crises, World Health Summit Closes in Berlin with New Commitments // Anthropic flags emerging self-replication risk across connected devices // Ransomware attackers target families as artificial intelligence spreads // IMF projects Asia-Pacific expansion easing through 2027 // Google introduces Gemini 4 Argon to AI Studio // Copper extends losing streak as US inflation accelerates // China Refuses To Be Labelled As A Developed Country, It Is Happy As A Developing Nation // IEA projects prolonged diesel supply squeeze through 2027 // Siam Paragon Bangkok International Fashion Week 2026 Unites Thai Designers to Drive the Future of Thailand’s Fashion Industry // Indonesia wildfire haze darkens skies, closes Timor schools // Microsoft and G42 detail AI agents in investment decisions // Hong Kong regulator widens crackdown on IPO manipulation // Standard Chartered brings direct cryptocurrency trading to UAE clients // AI features in 84% of surveyed ransomware incidents // Legal & General shields sovereign bond purchases with futures // Dubai Aerospace targets $2.1 billion dual-currency financing // ZTE Hong Kong and LSCM Sign Memorandum of Understanding to Advance Hong Kong’s Digital and Intelligent Development // Discover Surprising Southern Taiwan: Taiwan Tourism Administration Teams Up with Airlines & Travel Platforms with Multi-Million Rewards for International Travelers // GFH Partners transfers Chicago logistics facility for $151 million // Houthi missile fragments injure expatriate in Riyadh //

MIMS celebrates 60 years of empowering healthcare communities

“Pioneering spirit” since 1963 continues with new markets, new app/website, new insights and more for 2023 and beyond

SINGAPORE – Media OutReach – 24 May 2023 – MIMS Pte Ltd, Asia’s largest multi-channel provider of drug information, medical communications, events management, and marketing services, celebrates its 60th anniversary this year.

In September 1963, the company’s first medical information journal was published in Australia as “Monthly Index of Medical Specialties” – the acronym of which still occupies pride of place as the company’s name, MIMS.

See the company’s journey at https://corporate.mims.com/about-mims/

Empowering healthcare communities since 1963

To this day, MIMS lives up to its pioneering spirit and stays true to its vision of empowering healthcare communities across Asia – and beyond – as we will be launching several exciting initiatives:

  • New markets: We are actively growing our local team and expanding our business in the Middle East, working with global pharma companies.
  • New insights for the healthcare industry: We will be identifying and addressing gaps on medical information between healthcare professionals (HCPs) and pharma, with focus on content creation and delivery. The results of a multi-country survey will be out in Q3 2023.
  • Wider CME/CPD coverage: In addition to Singapore, Hong Kong, the Philippines, Malaysia and Indonesia, MIMS will be delivering locally relevant clinical content to HCPs across more Asian countries via free online modules at MIMS Education, https://education.mims.com
  • New eMIMSplus website and app: Launched this year to our Australian market, eMIMSplus is a major addition to the MIMS suite of products. Users can now access essential information quicker with the new interface and make more confident decisions with Australia’s most trusted medicine information provider. Learn more at https://emims.plus

“An incredible milestone”

CEO Masaki Takahata said on MIMS’ diamond anniversary: “Celebrating 60 years is an incredible milestone for any company and I am extremely proud and grateful.

It is a testament to the value MIMS brings to the healthcare industry, and the trust we receive from our clients and partners. This achievement is also not possible without our passionate and hardworking team members – past and present. Thank you all for your support!”

Throughout 2023, MIMS will be holding several activities to toast the people who have been instrumental in our journey.

Watch the video: MIMS reflects on 60 years at https://www.linkedin.com/company/mims-pte-ltd/

More diversified than ever

60 years on, the MIMS business is more diversified than ever, offering best in class services and innovation to drive insightful learning among doctors, healthcare companies, and the entire medical community.

To learn more about MIMS and our latest projects, go to: https://corporate.mims.com or follow us on LinkedIn (MIMS Pte Ltd)
Hashtag: #MIMS #MIMS60years #diamondanniversary #pioneers #empoweringhealthcarecommunities #pureknowledge #productinnovation #clientsatisfaction #AsiaPacific #ANZ #healthcare #medicalmarketing #medcomms #clinicaldecisionsolutions

The issuer is solely responsible for the content of this announcement.

About MIMS: Empowering Healthcare Communities to Improve Patient Outcomes

MIMS is Asia’s largest multi-channel provider of drug information, medical communications, events management, marketing, and recruitment services. Established in 1963, our work empowers healthcare professionals to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 18 markets globally with over two million healthcare professional subscribers to our drug & resource portal, digital and print publications.

Combining healthcare communications expertise with our established networks and presence in the Asian healthcare community, we enable clients to engage their stakeholders in meaningful dialogue through a range of medical and marketing communications services.

We facilitate long-term placement of nurses, pharmacists and doctors across the globe to match the demands of healthcare institutions looking for high calibre practitioners.

MIMS has offices in the following global markets:
Singapore (headquarters), Australia, China, Germany, Hong Kong SAR, Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New Zealand, Philippines, Taiwan, Thailand, UAE, Vietnam

Learn more at or follow us at



Notice an issue?

Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.


Loading next story…
Just in:
Microsoft and G42 detail AI agents in investment decisions // Standard Chartered brings direct cryptocurrency trading to UAE clients // Billion-dollar firms report wider gaps in security patching // IEA projects prolonged diesel supply squeeze through 2027 // US Treasury yields surge after inflation exceeds forecasts // GFH Partners transfers Chicago logistics facility for $151 million // Meta notifies 1,500 after GitHub code theft // ZTE Hong Kong and LSCM Sign Memorandum of Understanding to Advance Hong Kong’s Digital and Intelligent Development // UAE passport leads 2026 mobility ranking with 182 destinations // China Refuses To Be Labelled As A Developed Country, It Is Happy As A Developing Nation // Indonesia wildfire haze darkens skies, closes Timor schools // Siam Paragon Bangkok International Fashion Week 2026 Unites Thai Designers to Drive the Future of Thailand’s Fashion Industry // Google introduces Gemini 4 Argon to AI Studio // BR Shetty pursues $15bn damages against Bank of Baroda // Hong Kong regulator widens crackdown on IPO manipulation // Discover Surprising Southern Taiwan: Taiwan Tourism Administration Teams Up with Airlines & Travel Platforms with Multi-Million Rewards for International Travelers // A Women-Led Dubai Holiday Homes Operator Grows 42-Fold In Six Months // Ransomware attackers target families as artificial intelligence spreads // Houthi missile fragments injure expatriate in Riyadh // SMS Tan Kiat How, Rosianna Silalahi and Glenda Gloria to speak at PRISM Summit 2026 //